ScinoPharm was established in 1997 by a group of veteran pharmaceutical executives who had years of experience working for leading U.S. and international pharmaceutical companies. They helped lay the strong technical and quality foundation for ScinoPharm and also oversaw the establishment of a highly competent management team that is in charge today.
Chih-Hsien Lo | Chairman and General Chief Strategy Officer
Chairman of Uni-President Enterprises Corp.
Tsung-Ming Su | President and CEO
President of President International Development Corp., Chairman of President Life Sciences Co., Ltd.
Portia Lin | Vice-President of Marketing and Sales and Chief Strategy Officer | General Manager of ScinAnda Shanghai Biochemical Technology, Ltd.
Dr. Portia Lin began working at ScinoPharm in 1999, starting as a Research Scientist in R&D. After 2 years, in 2001, Dr. Lin was selected to join the Marketing & Sales group at ScinoPharm. She organized and initiated the group responsible for the development of sales for generic APIs. She is now in charge of the Marketing & Sales team for global sales activities for generic products and for ScinoPharm’s Contract Research and Manufacturing business. Dr. Lin holds a Ph.D. in chemistry from Hong Kong Polytech University, and a B.S and M.S. in chemistry from Chung-Hsing University in Taiwan.
Chih-Fang (Freon) Chen | Vice-President of Operations | General Manager of SciAnda (Changshu) Pharmaceuticals, Ltd.
Chih-Fang has more than 25 years of experience in chemical production management. He joined ScinoPharm in January, 1999 and has been in charge of the production unit for more than 15 years. Chih-Fang has been instrumental in enhancing productivity and production efficiency by introducing improvement initiatives and refining systems. Prior to joining ScinoPharm, Chih-Fang worked initially as process engineer, for Tasco Chemical Corporation in Kaohsiung and Tuntex Petrochemicals Inc. in Tainan from 1989 to 1998. Chih-Fang received both of his M.S. and B.S. in Chemical Engineering from National Cheng Kung University.
Li-An(Susan) Lu | Vice President of Administration and Spokesperson
As Vice President of Administration, Susan is responsible for human resources and administration, corporate communication activities, procurement and information technology operations. Experienced with the capital market, she is also responsible for corporate asset management and investment projects. She brings a wealth of experience in management and corporate finance and treasury. She was the team head for financial operation and corporate investment management in Uni-President Enterprises Corp. and was later promoted as the head of the Treasury Division where she was responsible for investment management and investor relations. Susan earned her M.S. from National Sun Yat-sen University in finance and B.S. in agricultural economics from National Taiwan University.
Gloria Chang | Vice President of Injectable Business Division and Chief Scientific Officer
Since joining the company in 1999, Dr. Chang has progressed through a series of increasingly responsible positions and had extensive experience in leading several important project initiatives. She had provided leadership to functional groups of quality control, analytical R&D, biotech, peptide product development, pharmaceutical development and the head of quality management division. Dr. Chang received her B.S. and Ph.D. degrees in Chemistry from National Taiwan University. Prior to joining ScinoPharm, she spent one and a half years as a postdoctoral fellow at Academia Sinica from 1997 to 1998.